Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | WU-NK-101 |
Trade Name | |
Synonyms | WU-NK 101|WU-NK101 |
Drug Descriptions |
WU-NK-101 are cytokine-reprogrammed natural-killer (NK) cells, which potentially induce cytotoxicity in tumor cells and antitumor activity (J Clin Oncol 41, no. 4_suppl (February 01, 2023) 170). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C180829 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetuximab + WU-NK-101 | Cetuximab WU-NK-101 | 0 | 1 |
WU-NK-101 | WU-NK-101 | 0 | 1 |